Your fact-checks will appear here
Bioinformatics and cheminformatics database from the University of Alberta
Drug information sources and health agencies report that ivermectin can interact with many medicines and substances — notably blood thinners, some cholesterol‑lowering drugs, antivirals, alcohol, and ...
Available sources report theoretical and case‑report concerns when ivermectin is combined with drugs that affect CYP3A4 and P‑glycoprotein — a group that can include some statins — potentially increas...
Available reporting and small studies identify three medication categories most commonly flagged as interacting with moringa: thyroid replacement (levothyroxine), antidiabetics, and cardiovascular dru...
Methylene blue is a potent monoamine oxidase A (MAO-A) inhibitor that can cause potentially fatal serotonin syndrome when combined with many serotonergic medications (SSRIs, SNRIs, TCAs, certain opioi...
Available clinical references show ivermectin is usually given as a single weight‑based oral dose for most human parasitic indications and is “generally well tolerated” at recommended doses; repeat do...
Prolonged or high‑dose ivermectin exposure is linked in clinical reports and reviews to neurological harms — including confusion, ataxia, seizures, and decreased consciousness — as well as gastrointes...
DMSO (dimethyl sulfoxide) is a widely used industrial solvent and cryoprotectant that is also an FDA‑approved prescription treatment only for bladder inflammation (interstitial cystitis) via intravesi...
Therapeutic ivermectin—approved in humans for parasitic infections—commonly causes gastrointestinal, neurologic, and dermatologic side effects such as nausea, diarrhea, dizziness, headache, and rash ....
Ivermectin’s approved, routine side effects are generally mild — itching, diarrhea, headache, dizziness and fatigue are commonly reported — but rare serious neurologic events (confusion, ataxia, seizu...
Ivermectin can interact with many prescription drugs — drug-interaction checkers list roughly 100+ interacting medicines and health authorities warn specifically about blood thinners — and some intera...
There are no universally agreed clinical guidelines that endorse off‑label high‑dose ivermectin for viral illnesses; major U.S. guidance notes that antiviral concentrations seen in vitro would require...
The FDA has not approved or authorized ivermectin for prevention or treatment of COVID‑19 in humans and explicitly warned people not to use veterinary formulations or high doses; overdoses can cause n...
Available reporting shows that mainstream drug references generally list few or no established drug–drug interactions for prescription L‑glutamine (Endari); WebMD and RxList state “no known interactio...
A targeted review of the supplied reporting finds no published clinical data for any drug or investigational product explicitly named “gelatide” in the provided sources; instead the literature is rich...
Available reporting finds no strong clinical evidence that hydrogen-infused (molecular hydrogen) water causes widespread, dangerous interactions with prescription drugs, and several reviews and vendor...
No FDA action specifically named “gelatide” appears in the provided material since 2020; the sources document FDA policy and listings about gelatin and related products — including GRAS status, export...
Gelatin itself — the protein derived from animal collagen — has no well-documented direct drug–drug interactions listed in major databases, but public-health guidance and recent analyses caution that ...
Amiodarone is a broad-spectrum Class III antiarrhythmic used to suppress life‑threatening ventricular and certain supra by prolonging cardiac repolarization and refractoriness, and it acts on multiple...
The categorical statement “No modern drugs exist for which raw patient datasets are available for independent analysis” is too broad: while truly open, fully de‑identified patient‑level clinical trial...
Public commitments to share de‑identified individual participant data (IPD) exist across the industry — notably the PhRMA/EFPIA pledge effective 1 January 2014 — but audits and reviews show that concr...